A major advance in cancer research is occurring with the use of nanobodies to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in several kinds of cancer, causing uncontrolled https://dmozbookmark.com/story21941024/nanobodies-reactivate-tumor-suppressor-p53-a-potential-pathway-for-cancer-therapy